[Drug therapy of arteriosclerotic circulatory disorders].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D004983:Ethanolamines / Q000627:therapeutic use; D005121:Extremities / Q000098:blood supply; D006801:Humans; D007263:Infusions, Parenteral; D009539:Nicotinic Acids / Q000627:therapeutic use; D011674:Pulse / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014970:Xanthines / Q000627:therapeutic use
D004983:Ethanolamines; D009539:Nicotinic Acids; D013565:Sympatholytics; D014665:Vasodilator Agents; D014970:Xanthines
Medikamentöse Therapie der arteriosklerotischen Durchblutungsstörungen